Programmdetails

Postervorträge

Aortic Disease and Mechanisms

Donnerstag, 4. April | 09:30 - 11:00 Uhr | Posterbereich 7

Vorsitz/Chair: Norbert Gerdes (Düsseldorf), Tienush Rassaf (Essen)

Agenda

(P479)
Absence of Protein Tyrosine Phosphatase-1B in vascular fibroblasts promotes cell proliferation, migration and pathological vascular remodeling
I. Ghasemi (Mainz)
(P480)
Uremic conditions induce structural weakening of the aorta via MMP-1-mediated degeneration of collagen I
A. Ackerschott (Bonn)
(P481)
Role of endocytosis and exocytosis in extracellular-vesicle-mediated arterial calcification.
A. Gorgels (Aachen)
(P482)
Investigating the Role of lncRNA GAS5 in Aortic Valve Calcification
Y. Zhou (Bonn)
(P483)
Inhibition of ceramide synthesis ameliorates calcific aortic valve disease by reducing lipotoxicity
E. Rawish (Lübeck)
(P484)
Investigating the role of uremic toxin indoxyl sulfate in aggravated aortic valve stenosis under uremic conditions
P. Düsing (Bonn)
(P485)
PI 3-Kinase/AKT/FOXO1 vermittelte Proliferation glatter Gefäßmuskelzellen vermindert die Progression abdominaler aortaler Aneurysmata
M. Vantler (Köln)
(P486)
Differential Expression of the CD163-Heme-Oxygenase 1 Axis in Autologous and Hemin Differentiated Monocyte-Derived Macrophages in Patients with Late Stage Abdominal Aortic Aneurysm
B. Hamann (Dresden)
Diese Seite teilen